← Back to headlines
Biotech Stocks Amylyx and Tyra Await Key Trial Data
Amylyx Pharmaceuticals (AMLX) and Tyra Biosciences (TYRA) are biotech companies whose stock performance is being watched closely ahead of key trial data releases for their respective LUCIDITY and SURF302 trials. Investors are anticipating the results to assess potential breakouts.
30 Jun, 13:09 — 30 Jun, 13:09
Sources
Showing 1 of 1 sources
